Meningococcal Disease
📧 Sign up to get email alerts when something new happens for Meningococcal Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-03-13Clinical Trial Update: Immunogenicity, Safety and Tolerability, of Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Premature and Non Premature Children of 3 Months of Age [Phase 3]
Phase 3 trial evaluating the immunogenicity, safety and tolerability of the Chiron Meningococcal C Conjugate Vaccine in healthy premature an…
-
CLINICAL_TRIALS trial_result · 2006-12-08Clinical Trial Update: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants [Phase 2]
Phase 2 trial assessing immune response in infants after primary vaccination with Tritanrix-HepB mixed with three Hib-MenAC vaccine formulat…
-
CLINICAL_TRIALS trial_result · 2006-10-26Clinical Trial Update: Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age [Phase 4]
Phase 4 trial update reporting safety, tolerability, and immunogenicity data for the Meningococcal C Conjugate Vaccine in children aged 32 t…